About the webinar

Subscribe to Curebase Content

Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.

Register now
WEBINAR
Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial
February 10, 2022

As the medical device clinical trial market is rapidly growing, so are the opportunities to augment traditional study designs with virtual trial sites and DCT solutions. However, there are a number of misconceptions about online patient recruitment, enrollment, and participation. In this session at SCOPE 2022, Jane Myles, VP of Clinical Trial Innovation at Curebase, busts seven of these “virtual site myths” using first-hand data from a gastroenterology digital therapeutics trial, and shares never-before-seen patient experience data.

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase.
Request a Meeting
Or, subscribe to our blog and other educational updates.
Reserve your spot today!

Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial

February 10, 2022
Featured speaker:
Jane Myles
VP of Clinical Trial Innovation, Curebase
Jane Myles
VP of Clinical Trial Innovation, Curebase
Feb 10, 2022 9:25 AM
EST
free
About the Webinar
Collaborate with patient representatives for software configuration and user testing
Assist patients along their treatment journey with patient-centric software and communication tools
Closely monitor data in real-time to gain actionable insights into the patient experience

As the medical device clinical trial market is rapidly growing, so are the opportunities to augment traditional study designs with virtual trial sites and DCT solutions. However, there are a number of misconceptions about online patient recruitment, enrollment, and participation. In this session at SCOPE 2022, Jane Myles, VP of Clinical Trial Innovation at Curebase, busts seven of these “virtual site myths” using first-hand data from a gastroenterology digital therapeutics trial, and shares never-before-seen patient experience data.

About Curebase
Curebase is reinventing decentralized clinical trials to help the vast majority of potential patients that currently cannot access clinical research. Our vision is that any patient, no matter where they are located, should be able to participate in clinical trials at home and with their own doctors. This is made possible through a unique suite of tools Curebase’s has designed to engage patients in clinical trials across all settings, be it at home, at their local clinic, or other places in their community.  

This starts with Curebase’s leading decentralized clinical trial software platform that is an all-in-one, purpose built eClinical software system, with every tool needed to manage and collect data for decentralized clinical trials. This includes ePRO, eCOA, eConsent, Telemedicine, and much more. Curebase also offers a virtual research site, complete with virtual investigators, research coordinators, mobile nursing, and other healthcare staff that administer care to patients where convenient for them, just like any other research site, but with the ability to stand up anywhere and with greater patient convenience and reach. Notably, Curebase is the pioneer of the “BYOP” or Bring Your Own Physician model, allowing patients to use their own doctors to participate in clinical trials. 

We are reinventing a $45B market, enabling drug and device companies to increase the volume, quality, and speed of data collection regardless of patients’ physical location. COVID-19 tailwinds have created massive demand for telemedicine and home-based trials, with two new FDA guidance letters and industry-wide adoption of remote remote research that will only accelerate in the years to come. You can learn more about Curebase and our next stage of growth in Crunchbase, Fierce Biotech, and MedCity News!

You can learn more in a 1-1 meeting with Curebase

We'd love to hear from you, whether a Sponsor interested in running a study with us, a provider looking to get involved in clinical research, or patients interested in our studies. Fill out your information below and one of our team members will be in touch.

Register for webinar

Subscribe to Curebase Content

Interested in staying up to date with Curebase's latest developments in the decentralized clinical trial space? Get regular updates on news, webinars, blogs and more by subscribing here.

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
548 Market St
PMB 86319
San Francisco, CA 94104-5401
United States
/script type="application/ld+json"> { "@context": "https://schema.org", "@type": "NewsArticle", "mainEntityOfPage": { "@type": "WebPage", "@id": "https://www.curebase.com/blog/comparing-virtual-and-traditional-sites-in-a-pivotal-medical-device-trial", "headline": "Comparing Virtual and Traditional Sites in a Pivotal Medical Device Trial", "image": "https://assets-global.website-files.com/5d4505c3350234080d3951b4/6324f00f1781225a728639a6_notext.2.5.jpg", "datePublished": "Feb 10, 2022", "dateModified": "Sep 16, 2022" }, "publisher": { "@type": "Organization", "name": "Curebase", "logo": { "@type": "ImageObject", "url": "https://assets-global.website-files.com/5d3a281a9a4d7b845a9c02b2/626eb4f1d608a41e03a15062_curebase-logo-color-light%20(1)%201.svg" } }, "description": "Jane Myles, VP of Clinical Trial Innovation at Curebase, presents at SCOPE 2022 on the impact of technology on a gastroenterology DTx study" } /script>